19-55038944-A-G

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -12 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_Strong

The XR_001754012.3(GP6-AS1):n.122-3856A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. Note: XR_001754012.3 is not a MANE Select or MANE Plus Clinical transcript for GP6-AS1; the reported annotation may differ from that of the MANE-designated reference transcript for this gene. The variant allele was found at a cumulative frequency of 0.813 (AC=123,695) in the gnomAD database across 152,064 control chromosomes, including 50,699 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.953. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.81 ( 50699 hom., cov: 31)

Consequence

GP6-AS1
XR_001754012.3 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.163

Publications

9 publications found
Variant links:
Genes affected
GP6-AS1 (HGNC:55305): (GP6 antisense RNA 1)
RDH13 (HGNC:19978): (retinol dehydrogenase 13) This gene encodes a mitochondrial short-chain dehydrogenase/reductase, which catalyzes the reduction and oxidation of retinoids. The encoded enzyme may function in retinoic acid production and may also protect the mitochondria against oxidative stress. Alternatively spliced transcript variants have been described. [provided by RefSeq, Mar 2009]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript XR_001754012.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript

Our verdict: Benign. The variant received -12 points.

BP4
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); No splicing predictor data available.; Germline computational verdict: benign (Strong).
BA1
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.9532 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: ENST00000585492.1. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ENSG00000267149
ENST00000585492.1
TSL:2
n.1001+5961T>C
intron
N/A
GP6-AS1
ENST00000586845.1
TSL:3
n.134-3888A>G
intron
N/A
GP6-AS1
ENST00000586961.1
TSL:5
n.45-3888A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.814
AC:
123612
AN:
151946
Hom.:
50673
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.715
Gnomad AMI
AF:
0.770
Gnomad AMR
AF:
0.854
Gnomad ASJ
AF:
0.772
Gnomad EAS
AF:
0.976
Gnomad SAS
AF:
0.805
Gnomad FIN
AF:
0.891
Gnomad MID
AF:
0.851
Gnomad NFE
AF:
0.843
Gnomad OTH
AF:
0.825
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.813
AC:
123695
AN:
152064
Hom.:
50699
Cov.:
31
AF XY:
0.819
AC XY:
60852
AN XY:
74336
show subpopulations
African (AFR)
AF:
0.715
AC:
29636
AN:
41444
American (AMR)
AF:
0.854
AC:
13012
AN:
15244
Ashkenazi Jewish (ASJ)
AF:
0.772
AC:
2677
AN:
3468
East Asian (EAS)
AF:
0.976
AC:
5046
AN:
5172
South Asian (SAS)
AF:
0.805
AC:
3875
AN:
4816
European-Finnish (FIN)
AF:
0.891
AC:
9460
AN:
10612
Middle Eastern (MID)
AF:
0.850
AC:
250
AN:
294
European-Non Finnish (NFE)
AF:
0.843
AC:
57298
AN:
67994
Other (OTH)
AF:
0.825
AC:
1739
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1165
2329
3494
4658
5823
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
880
1760
2640
3520
4400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.824
Hom.:
75137
Bravo
AF:
0.805
Asia WGS
AF:
0.884
AC:
3074
AN:
3478

Local populations

ToMMo 61KJPN (+60KJPN MNV)
AF:
0.981
AC:
120280
AN:
122656
Turkish Variome
AF:
0.828
AC:
1280
AN:
1546
Hom.:
537
WBBC (Westlake BioBank for Chinese) pilot
AF:
0.980
AC:
8784
AN:
8960
Hom.:
4309
ABraOM SABE-WGS-1171
AF:
0.819
AC:
1919
AN:
2342
Hom.:
792

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
2.4
DANN
Benign
0.40
PhyloP100
-0.16

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.